BluePath Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Sell |
406
-30
| -7% | -$23.4K | 0.15% | 84 |
|
|
2025
Q1 | $360K | Sell |
436
-1,144
| -72% | -$946K | 0.21% | 80 |
|
|
2024
Q4 | $1.26M | Buy |
1,580
+999
| +172% | +$797K | 0.68% | 31 |
|
|
2024
Q3 | $515K | Buy |
581
+2
| +0.3% | +$1.77K | 0.32% | 76 |
|
|
2024
Q2 | $524K | Sell |
579
-28
| -5% | -$25.4K | 0.37% | 77 |
|
|
2024
Q1 | $472K | Sell |
607
-141
| -19% | -$110K | 0.36% | 74 |
|
|
2023
Q4 | $471K | Buy |
748
+33
| +5% | +$20.8K | 0.4% | 57 |
|
|
2023
Q3 | $384K | Buy |
+715
| New | +$384K | 0.35% | 58 |
|